KEUTZER TIMOTHY (Chief Development Officer) sold 0.6% of their position (1.85K shares) of SPERO THERAPEUTICS, INC. on the open market
Open‑market sale worth $2.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/30/2023ACC: 0000950170-23-045450
Officer· Chief Development Officer
Since Jan 2020
-1.85K
Net shares
Net seller
$2.3K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.85K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.85K
Price / share
$1.26
Trade value
$2.34K
% of position
0.6%
8/28/2023
327.14K→325.29K
Total
Net shares
−1.85K
Net value
-$2.34K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/28/2023 | S · Sale | −1.85K | $1.26 | $2.34K | 0.6% | 327.14K | 325.29K |
| Total | −1.85K | -$2.34K | ||||||
Derivative Transactions0
No derivative transactions reported